LeMaitre Vascular Q4 2023 GAAP EPS $0.38 Beats $0.36 Estimate, Sales $48.88M Miss $49.02M Estimate
Portfolio Pulse from Benzinga Newsdesk
LeMaitre Vascular (LMAT) reported Q4 2023 earnings of $0.38 per share, surpassing the $0.36 estimate, but missed sales estimates with $48.88M against the expected $49.02M. This represents a 19.36% increase in sales compared to the same period last year.
February 27, 2024 | 9:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LeMaitre Vascular reported higher than expected Q4 2023 earnings per share but slightly missed sales estimates. Year-over-year sales saw a significant increase.
The positive earnings surprise and the significant year-over-year sales growth are likely to be viewed favorably by investors, potentially leading to a short-term positive impact on LMAT's stock price. However, the slight miss on sales estimates could temper some of the positive sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100